L&K Biomed Ltd. (KOSDAQ:156100)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Manufacture and Sale of Medical Devices	36.09B	29.90B	19.77B	15.37B	19.36B
Manufacture and Sale of Medical Devices Growth	20.69%	51.28%	28.59%	-20.58%	-27.16%
Total	36.09B	29.90B	19.77B	15.37B	19.36B
Total Growth	20.69%	51.28%	28.59%	-20.58%	-27.16%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
USA	24.59B	21.82B	-	10.29B	13.73B
USA Growth	12.69%	-	-	-25.01%	-
South Korea	1.48B	2.44B	659.84M	2.72B	2.74B
South Korea Growth	-39.27%	270.02%	-75.78%	-0.48%	-75.41%
Thailand	4.12B	2.49B	-	895.19M	-
Thailand Growth	65.60%	-	-	-	-
Other	5.89B	3.15B	-	1.46B	2.69B
Other Growth	87.08%	-	-	-45.76%	-
Overseas	-	-	19.11B	-	-
Australia	-	-	-	-	201.04M
Total	36.09B	29.90B	19.77B	15.37B	19.36B
Total Growth	20.69%	51.28%	28.59%	-20.58%	-24.91%

Source: S&P Global Market Intelligence.